Orexin, also known as hypocretin, is a brain hormone that helps regulate sleep. A deficiency of this hormone can cause a person to develop type 1 narcolepsy. Type 1 narcolepsy, formerly known as ...

FDA approval positions oral selective OX2R agonism as a first-in-class approach intended to restore orexin signaling and mitigate wake–REM instability underlying narcolepsy type 1 with cataplexy.

We conducted a phase 2, randomized, placebo-controlled trial of TAK-994, an oral orexin receptor 2–selective agonist, in patients with narcolepsy type 1. Patients with confirmed narcolepsy type 1 ...

Narcolepsy is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. People with narcolepsy often find it difficult to stay awake for long periods of ...

A new Northwestern Medicine study has demonstrated a new way to treat narcolepsy-related nightmares. The scientists combined cognitive behavioral therapy (CBT) and lucid dreaming to help patients in a ...

Narcolepsy and idiopathic hypersomnia (IH) both lead to daytime sleepiness, fatigue, and brain fog. Narcolepsy can involve muscle weakness and sleep paralysis, while IH may lead to non-refreshing ...

YEARS. I WAS ACTUALLY ONE OF THE LUCKY ONES. IT TOOK JUST OVER THREE YEARS ON AVERAGE. A NARCOLEPSY DIAGNOSIS CAN TAKE 8 TO 15 YEARS. IT’S JUST VERY UNDER-RECOGNISED. YOU KNOW, IN PHYSICIANS IT CAN ...

The U.S. FDA has granted Fast Track designation to Lu AH69593, an oral orexin 2 receptor agonist, for the treatment of patients with narcolepsy The orexin 2 receptor is critically located in the main ...

Add Yahoo as a preferred source to see more of our stories on Google. Narcolepsy—Comprehensive overview covers symptoms, causes, treatment of overwhelming daytime sleepiness. Narcolepsy is a chronic ...